DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Montalban X, Hemmer B, Rammohan K , et al.
Efficacy and safety of ocrelizumab in primary progressive multiple sclerosis—results of the phase III double-blind, placebo controlled ORATORIO Study.
Presented at: 31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis; October 10, 2015; Barcelona, Spain
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.